Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

INNOVATE (HCHC) Competitors

INNOVATE logo

HCHC vs. PRLB, GIFI, VATE, TPCS, VMI, and ACA

Should you be buying INNOVATE stock or one of its competitors? The main competitors of INNOVATE include Proto Labs (PRLB), Gulf Island Fabrication (GIFI), INNOVATE (VATE), TechPrecision (TPCS), Valmont Industries (VMI), and Arcosa (ACA).

INNOVATE vs.

Proto Labs (NYSE:PRLB) and INNOVATE (NYSE:HCHC) are both small-cap industrial products companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, profitability and institutional ownership.

Proto Labs has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, INNOVATE has a beta of 2.31, meaning that its share price is 131% more volatile than the S&P 500.

Proto Labs has a net margin of 4.76% compared to INNOVATE's net margin of -3.10%. Proto Labs' return on equity of 3.49% beat INNOVATE's return on equity.

Company Net Margins Return on Equity Return on Assets
Proto Labs4.76% 3.49% 3.14%
INNOVATE -3.10%-15.62%-1.13%

Proto Labs has higher earnings, but lower revenue than INNOVATE.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Proto Labs$503.88M1.92$17.22M$0.9440.93
INNOVATE$1.01B0.40-$92MN/AN/A

84.5% of Proto Labs shares are owned by institutional investors. Comparatively, 36.5% of INNOVATE shares are owned by institutional investors. 1.2% of Proto Labs shares are owned by insiders. Comparatively, 43.5% of INNOVATE shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Proto Labs currently has a consensus target price of $40.33, suggesting a potential upside of 4.84%. Given Proto Labs' stronger consensus rating and higher possible upside, equities research analysts clearly believe Proto Labs is more favorable than INNOVATE.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Proto Labs
0 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.50
INNOVATE
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Proto Labs received 55 more outperform votes than INNOVATE when rated by MarketBeat users. Likewise, 62.88% of users gave Proto Labs an outperform vote while only 53.02% of users gave INNOVATE an outperform vote.

CompanyUnderperformOutperform
Proto LabsOutperform Votes
327
62.88%
Underperform Votes
193
37.12%
INNOVATEOutperform Votes
272
53.02%
Underperform Votes
241
46.98%

In the previous week, Proto Labs had 23 more articles in the media than INNOVATE. MarketBeat recorded 23 mentions for Proto Labs and 0 mentions for INNOVATE. Proto Labs' average media sentiment score of 0.32 beat INNOVATE's score of 0.32 indicating that Proto Labs is being referred to more favorably in the media.

Company Overall Sentiment
Proto Labs Neutral
INNOVATE Neutral

Summary

Proto Labs beats INNOVATE on 14 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCHC vs. The Competition

MetricINNOVATEFabricated Structural Metal Products IndustryConglomerates SectorNYSE Exchange
Market Cap$401.55M$2.19B$16.60B$20.10B
Dividend YieldN/A0.45%2.79%3.54%
P/E Ratio-7.9415.773.9841.83
Price / Sales0.401.240.5716.68
Price / Cash63.9713.3033.2120.75
Price / Book0.662.560.315.28
Net Income-$92M$42.21M$1.79B$988.95M

INNOVATE Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCHC
INNOVATE
N/A$5.16
+0.4%
N/A+375.9%$401.55M$1.01B-7.942,803Gap Up
PRLB
Proto Labs
2.6337 of 5 stars
$38.00
+38.7%
N/A+14.5%$955.70M$503.88M39.582,415Earnings Report
High Trading Volume
GIFI
Gulf Island Fabrication
1.2471 of 5 stars
$5.44
-1.3%
N/A+67.2%$89.87M$151.07M-4.81960Earnings Report
Analyst Upgrade
News Coverage
VATE
INNOVATE
0.3258 of 5 stars
$5.92
+0.9%
N/A-56.3%$77.27M$1.36B-1.794,024Gap Down
TPCS
TechPrecision
0.458 of 5 stars
$3.34
-5.6%
N/A-50.2%$32.13M$31.59M-4.12160Gap Down
VMI
Valmont Industries
4.0175 of 5 stars
$316.13
+1.4%
N/A+74.5%$6.33B$4.05B21.4811,125Positive News
ACA
Arcosa
4.003 of 5 stars
$93.69
+0.1%
N/A+54.6%$4.57B$2.31B35.626,075

Related Companies and Tools


This page (NYSE:HCHC) was last updated on 11/8/2024 by MarketBeat.com Staff
From Our Partners